Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repurposing Lithium as a Disease-modifying Therapy in Parkinson's Disease: an Open-label Extension Trial.

NCT06592014 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.

NCT NCT06592014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06592014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repurposing Lithium as a Disease-modifying Therapy in Parkinson's Disease: an Open-label Extension Trial.
Lead sponsor
State University of New York at Buffalo
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
August 9, 2024
Completion date
November 1, 2026
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease